APIs and Excipients

Cambrex Adds Reactors to Facility in Sweden

September 26, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Additional reactor capacity and a wastewater processing plant increase API manufacturing capacity at the Cambrex site in Kalskoga, Sweden.

ADC Bio Invests $11 Million on Bioconjugation Facility

September 26, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.

BASF Plans Amine Facility in Nanjing

September 25, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China.

Ajinomoto Althea Adds High Potency Capabilities

September 21, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.

Using Simulation to Address Capacity Limitations

September 02, 2017

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.

Expediting the Discovery and Development of Drugs

September 02, 2017

Drug repurposing, repositioning, and rescue can be faster, cheaper, and target more diseases than traditional drug discovery approaches.

Roquette Acquires Itacel

September 01, 2017

Roquette has completed its previously announced acquisition of Itacel, an excipient division of Blanver.

Applying QbD in Process Development

September 01, 2017

Informatics software can be used to address the challenges of quality by design, such as managing impurity data when developing an impurity control strategy.

A Multifunctional Mineral Excipient

September 01, 2017

Functionalized calcium carbonate provides high porosity, which enables fast disintegration, and excellent compactibility that results in harder tablets at low compression forces.

New Technologies Optimize API and Drug Product Manufacturing

September 01, 2017

Innovative new technologies released over the past several months seek to enhance bio/pharmaceutical development and manufacturing.